Preferred
(EDT)

Vaccines as Drugs for COVID‑19

9:00 AM - 11:35 AM EST
Thursday, January 14, 2021
Other
Vaccines as Drugs for COVID‑19
The Challenges of a New Vaccine for a New Disease
9:00 AM - 9:15 AM EST
Thursday, January 14, 2021
Speaker
Speaker Image
Liise-anne Pirofski, MD
Albert Einstein College of Medicine and Montefiore Medical Center
Vaccines as Drugs for COVID‑19
Development of a Self‑Amplifying RNA Vaccine for COVID‑19
9:15 AM - 9:30 AM EST
Thursday, January 14, 2021
Speaker
Speaker Image
Paul McKay, PhD
Imperial College
Vaccines as Drugs for COVID‑19
Speaker
Speaker Image
Andrea Carfi, PhD
Moderna
Vaccines as Drugs for COVID‑19
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
9:45 AM - 10:00 AM EST
Thursday, January 14, 2021
Speaker
Speaker Image
Alexander Muik, PhD
BioNTech
Vaccines as Drugs for COVID‑19
Development of INO-4800, a DNA Vaccine for COVID-19
10:00 AM - 10:15 AM EST
Thursday, January 14, 2021
Speaker
Vaccines as Drugs for COVID‑19
Speaker
Speaker Image
Sarah Gilbert, PhD
University of Oxford
Vaccines as Drugs for COVID‑19
Coffee Break
10:30 AM - 10:45 AM EST
Thursday, January 14, 2021
Vaccines as Drugs for COVID‑19
Speaker
Speaker Image
Hanneke Schuitemaker, PhD
Janssen Vaccines & Prevention B.V.
Vaccines as Drugs for COVID‑19
Development of the mRNA based SARS-CoV-2 Vaccine CVnCoV
11:00 AM - 11:15 AM EST
Thursday, January 14, 2021
Speaker
Speaker Image
Susanne Rauch
CureVac GmbH
Vaccines as Drugs for COVID‑19
Closing Remarks
11:30 AM - 11:35 AM EST
Thursday, January 14, 2021
Vaccines as Drugs for COVID‑19

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.